Breast Cancer Clinical Trial

A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan

Summary

The overall goal of this study is to explore the effectiveness of using acupuncture versus aromatherapy, in conjunction with standard of care anti-emetics, to decrease chemotherapy induced nausea, vomiting, and anxiety in breast cancer patients undergoing Adriamycin and Cytoxan. This study also aims to determine if aromatherapy and anti-emetics is more effective than acupuncture and anti-emetics in treating nausea, vomiting, and anxiety in patients receiving Adriamycin and Cytoxan and if acupuncture and anti-emetics is more effective than aromatherapy and anti-emetics in treating nausea, vomiting, and anxiety in patients receiving Adriamycin and Cytoxan.

View Eligibility Criteria

Eligibility Criteria

i) Inclusion

At least 18 years of age on the day of signing informed consent
Patient has a diagnosis of breast cancer
Patient is planned to start Adriamycin and Cytoxan chemotherapy

ii) Exclusion

Patients who are unable to adhere to the protocol or treatment schedule
Patients who have a concurrent illness or take medication that induces nausea independent of chemotherapy
Patients undergoing radiotherapy or hormone therapy during chemotherapy treatments
Patients who have a sensitive and/or poor sense of smell
Patients who are allergic to essential oils, specifically peppermint, ginger, and/or lavender
Patients who are already using essential oils or acupuncture for symptom management and are unwilling to stop while participating in this study
Patients who are afraid of or unwilling to receive acupuncture stimulation
Patients who are allergic to stainless steel needles
Thrombocytopenia (Platelets < 20,000)
Patients who have received aromatherapy and/or acupuncture treatment within 1 week of starting treatment on this study

Study is for people with:

Breast Cancer

Estimated Enrollment:

60

Study ID:

NCT04116697

Recruitment Status:

Recruiting

Sponsor:

Englewood Hospital and Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Englewood Health
Englewood New Jersey, 07631, United States More Info
Jamie Ketas
Contact
201-894-3418
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

60

Study ID:

NCT04116697

Recruitment Status:

Recruiting

Sponsor:


Englewood Hospital and Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.